Acquired Resistance Mechanisms to Osimertinib in EGFR Mutant Lung Cancer

ABSTRACT: Acquired Resistance Mechanisms to Osimertinib in EGFR Mutant Lung Cancer

PROVIDER: PRJNA616048 | ENA |

REPOSITORIES: ENA